ra.vermeulen
Submits third-party assay reports on material purchased directly. Based in Turku.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.31%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042849 | Retatrutide | GGPeps | GGPE-2511-X1688 | Kestrel | 2026-Q2 | 99.31 | 5.32 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042602 | Tirzepatide | GGPeps | GGPE-2604-H8313 | PeptideMeter | 2026-Q2 | 99.59 | 1.92 | 89.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043082 | Tirzepatide | KP | KP-2605-E6030 | Medutest | 2026-Q2 | 98.25 | 4.08 | 103.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041750 | Cagrilintide | FGP | FGP-2602-M9870 | Medutest | 2026-Q2 | 98.58 | 3.43 | 93.1 | Supplier-supplied | 0 | PASS |
| AX-2026-043163 | Retatrutide | SSA | SSA-2601-T7702 | Medutest | 2026-Q1 | 98.90 | 5.14 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019216 | BPC-157 | TFC | TFC-2508-W5717 | Janoshik | 2025-Q3 | 99.32 | 3.74 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021048 | Semaglutide | WXT | WXT-2508-G4316 | Medutest | 2025-Q3 | 97.94 | 3.46 | — | Laboratory-retained | 2 | MARGINAL |
| AX-2025-018675 | GHRP-6 | QYB | QYB-2504-H5763 | Nordanalyt | 2025-Q2 | 99.61 | 6.20 | 93.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004232 | GHRP-6 | WWB | WWB-2401-U3578 | PeptideMeter | 2024-Q2 | 99.93 | 2.08 | 93.2 | Supplier-supplied | 1 | MARGINAL |